z-logo
open-access-imgOpen Access
Dysrhythmias and Hypertension
Author(s) -
Timothy J. Byrnes,
David T. Huang
Publication year - 2020
Publication title -
hypertension journal
Language(s) - English
Resource type - Journals
eISSN - 2455-4987
pISSN - 2454-5996
DOI - 10.15713/ins.johtn.0176
Subject(s) - medicine , cardiology
Cardiovascular disease is the leading cause of death in the world,[1] as well as the United States and India for the past 80+ years[2] and 16 years,[3] respectively. The death rate per 100,000 population in the United States is 262.3[4] and India is 209.1.[5] There are a variety of risk factors for cardiovascular disease, but likely none more significant than hypertension (HTN).[6] More than a quarter of the population of both the United States (29.0%)[7] and India (29.8%)[8] have a diagnosis of HTN. Despite the well understood morbidity and mortality associated with HTN, only 48.3% of the United States’[7] and 10.7–20.2% of India’s[8] hypertensive population are adequately treated. Historically, HTN has been defined as a blood pressure (BP) >140/90 mmHg,[9] but a change to >130/80 mmHg has been recommended[10] following the SPRINT Trial.[11] This is would result in a dramatic increase in the prevalence of HTN throughout the world, including up to 46% of the entire United States population.[12] The patients responsible for this increase in prevalence would primarily be younger,[13] which could be beneficial as several studies have shown that BP > 130/80 mmHg is associated with poorer outcomes in patients <65 years old.[14–16] In addition to ischemic heart disease, stroke, vascular disease, and renal insufficiency, HTN can cause hypertensive heart disease, even with BPs of 120–139/80–89 mmHg.[17,18] Hypertensive Heart Disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom